Literature DB >> 22809947

Results of questionable management protocols are inherently questionable.

Jean-Louis Teboul, Xavier Monnet, Azriel Perel.   

Abstract

Mesh：

Year:  2012        PMID： 22809947     DOI： 10.1097/CCM.0b013e3182545759

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  6 in total

1.  Goal-directed therapy: hit early and personalize!

Authors:  Bernd Saugel; Frederic Michard; Thomas W L Scheeren
Journal:  J Clin Monit Comput       Date:  2017-06-26       Impact factor: 2.502

2.  Less invasive hemodynamic monitoring in critically ill patients.

Authors:  Jean-Louis Teboul; Bernd Saugel; Maurizio Cecconi; Daniel De Backer; Christoph K Hofer; Xavier Monnet; Azriel Perel; Michael R Pinsky; Daniel A Reuter; Andrew Rhodes; Pierre Squara; Jean-Louis Vincent; Thomas W Scheeren
Journal:  Intensive Care Med       Date:  2016-05-07       Impact factor: 17.440

3.  Effectiveness of treatment based on PiCCO parameters in critically ill patients with septic shock and/or acute respiratory distress syndrome: a randomized controlled trial.

Authors:  Zhongheng Zhang; Hongying Ni; Zhixian Qian
Journal:  Intensive Care Med       Date:  2015-01-21       Impact factor: 17.440

Review 4.  Advanced Hemodynamic Management in Patients with Septic Shock.

Authors:  Bernd Saugel; Wolfgang Huber; Axel Nierhaus; Stefan Kluge; Daniel A Reuter; Julia Y Wagner
Journal:  Biomed Res Int       Date:  2016-09-14       Impact factor: 3.411

Review 5.  Effective hemodynamic monitoring.

Authors:  Michael R Pinsky; Maurizio Cecconi; Michelle S Chew; Daniel De Backer; Ivor Douglas; Mark Edwards; Olfa Hamzaoui; Glenn Hernandez; Greg Martin; Xavier Monnet; Bernd Saugel; Thomas W L Scheeren; Jean-Louis Teboul; Jean-Louis Vincent
Journal:  Crit Care       Date:  2022-09-28       Impact factor: 19.334

Review 6.  Transpulmonary thermodilution: advantages and limits.

Authors:  Xavier Monnet; Jean-Louis Teboul
Journal:  Crit Care       Date:  2017-06-19       Impact factor: 9.097
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.